Caxton Advantage

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 1, 2012	Regado Biosciences	$51.0M Series E	RusnanoMedInvest	Domain Associates, Aurora Funds, Baxter Ventures, Quaker Partners
Dec 1, 2009	Regado Biosciences	$40.0M Series D	—	Domain Associates, Aurora Funds, Quaker Partners

Total Raised

N/A

Valuation

N/A